SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 78 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $73,375 | -8.9% | 16,415 | +52.5% | 0.00% | 0.0% |
| Q1 2021 | $80,515 | -40.7% | 10,764 | -13.9% | 0.00% | -50.0% |
| Q4 2020 | $135,679 | +22.7% | 12,505 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $110,544 | -17.1% | 12,505 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $133,303 | +83.9% | 12,505 | +2.3% | 0.00% | 0.0% |
| Q1 2020 | $72,494 | -47.4% | 12,225 | -8.0% | 0.00% | 0.0% |
| Q3 2019 | $137,940 | +414.0% | 13,289 | +358.6% | 0.00% | – |
| Q2 2019 | $26,835 | -75.7% | 2,898 | -68.7% | 0.00% | -100.0% |
| Q3 2018 | $110,251 | -99.9% | 9,257 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $94,514,000 | +60485.9% | 9,257 | -4.5% | 0.00% | +100.0% |
| Q2 2017 | $156,000 | – | 9,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 200,000 | $1,768,000 | 8.83% |
| Samsara BioCapital, LLC | 1,407,949 | $11,608,000 | 3.24% |
| Flagship Pioneering Inc. | 2,938,494 | $25,976,000 | 0.72% |
| ARK Investment Management | 11,212,506 | $99,119,000 | 0.59% |
| Portolan Capital Management | 450,861 | $3,986,000 | 0.45% |
| Capital Impact Advisors, LLC | 168,600 | $1,490,000 | 0.44% |
| Nikko Asset Management Americas, Inc. | 4,182,346 | $36,261,000 | 0.32% |
| Sio Capital Management, LLC | 166,780 | $1,474,000 | 0.29% |
| Virtus ETF Advisers LLC | 34,835 | $308,000 | 0.16% |
| Artal Group S.A. | 465,500 | $4,115,000 | 0.10% |